Granisetron Hydrochloride NDC 69452-350

NDC codes

FDA NDC Directory

Product NDC (as listed)69452-350Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69452-0350Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
69452-350-01	69452035001	2 BLISTER PACK in 1 CARTON (69452-350-01) / 1 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Feb 28, 2022
69452-350-11	69452035011	20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69452-350-11)Marketed from Feb 28, 2022
69452-350-92	69452035092	2 BLISTER PACK in 1 CARTON (69452-350-92) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Feb 28, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Granisetron Hydrochloride
Generic name (nonproprietary): granisetron hydrochloride
Active ingredients: Granisetron hydrochloride — 1 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Bionpharma Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078678
Marketing start: Feb 28, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 3 Receptor Antagonists (Mechanism)
Identifiers: Product ID 69452-350_cfe3b317-aba5-46b3-83fd-df5a6d71ea76SPL ID cfe3b317-aba5-46b3-83fd-df5a6d71ea76SPL set ID 50b713d3-7ca8-465a-aefa-65ddbe17b934RxCUI 310599UNII 318F6L70J8
Pharmacologic class: Serotonin-3 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469452035001 followed by a unit qualifier and the quantity

Package 69452-0350-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 16, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Granisetron hydrochloride tablets are indicated for the prevention of: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)